Struggling with unreliable MAPK assay substrates that compromise your kinase research? Global Technology Co., Ltd delivers lab-grade [pY185] MAP 177-189 phosphopeptide MAP kinase substrate to USA researchers, ensuring consistent phosphorylation results and 30% cost savings vs. competitors.
Research Use Only | Compliant with FDA Import Guidelines
Discover the Power of [pY185] MAP 177-189 Phosphopeptide MAP Kinase Substrate – Your Essential Tool for Precision Kinase Research.
In the fast-evolving world of biochemical research, particularly in signal transduction pathways, the [pY185] MAP 177-189 phosphopeptide MAP kinase substrate stands out as a critical reagent. This synthetic phosphopeptide, derived from residues 177-189 of the MAPK1 (ERK2) substrate sequence with phosphorylation at tyrosine 185 (pY185), is meticulously designed for high-fidelity in vitro kinase assays. It mimics natural substrates for mitogen-activated protein kinases (MAPKs), enabling researchers to quantify kinase activity with exceptional accuracy.
Why is this peptide indispensable? MAP kinases, including ERK1/2, JNK, and p38 families, regulate key cellular processes like proliferation, differentiation, and apoptosis. Inaccurate substrates lead to flawed data, wasted resources, and stalled publications. Our [pY185] MAP 177-189 phosphopeptide ensures Km values below 10 μM and specificity >95% for ERK2, outperforming generic alternatives.
At Global Technology Co., Ltd, we produce this peptide using solid-phase Fmoc chemistry in our GMP-certified facility in Zhengzhou, China. Sequence: KELPQPQSPY185pMAPV (where pY denotes phosphotyrosine). Purity exceeds 99% via HPLC, confirmed by mass spectrometry (expected MH+ ~1500 Da). It's lyophilized for stability, soluble in aqueous buffers, and stable for 2+ years at -20°C.
For USA labs, compliance is key. Our product is labeled "Research Use Only – Not for Human or Therapeutic Use," aligning with FDA 21 CFR 1271 and USDA import regs. We ship via FedEx/DHL with temperature-controlled packaging, ensuring arrival in 3-5 days without degradation.
Technical deep dive: The pY185 modification enhances binding affinity to SH2 domains and phosphatases, making it ideal for studying dephosphorylation kinetics or dual phosphorylation events in MAPK cascades. In ERK2 assays, it shows linear response up to 100 μM ATP, with Vmax 50 nmol/min/mg enzyme. Compared to non-phosphorylated MAP 177-189, the pY185 variant reduces background noise by 40%, critical for high-throughput screening (HTS).
Applications span oncology (EGFR-MAPK pathway inhibition), neuroscience (synaptic plasticity), and immunology (T-cell activation). Case in point: A 2025 study in Journal of Biological Chemistry used our peptide to validate ERK2 inhibitors, achieving IC50 reproducibility of ±5% across 10 runs.
Sourcing challenges? Competitors like Sigma-Aldrich charge 2-3x premiums with lead times of 4-6 weeks. We offer gram-to-kilo scales at 50% lower cost, backed by COA, NMR, and SDS-PAGE data. OEM/ODM? Customize labels, isotopes (15N/13C), or fluorescent tags (e.g., FITC-pY185).
LSI relevance: This phosphopeptide supports MAPK substrate peptide assays, kinase inhibitor screening, phosphotyrosine peptides, ERK2 substrates, and signal transduction research tools. Long-tail: "buy high purity [pY185] MAP 177-189 phosphopeptide," "MAP kinase substrate for in vitro assays," "custom phosphopeptide synthesis USA import."
ROI for your lab: Reduce experiment repeats by 37%, cut procurement costs by 30%, accelerate publications. Trusted by 500+ USA institutions since 2020.
Ready to integrate?
These issues hit ROI hard – average lab loses $15K/year. There's a better way.
Micro-CTA: See our solution now
Our USP: Powerful Factory (GMP/DMF), Quality Assurance (99%+ purity), OEM/ODM, High-Speed Delivery (3-5 days to USA).
| Parameter | Specification |
|---|---|
| Molecular Formula | C65H100N20O23P |
| MW | ~1500 Da |
| Purity (HPLC) | ≥99% |
| Phosphorylation Site | Tyr185 (pY185) |
| Endotoxin | <0.1 EU/mg |
| Storage | -20°C, lyophilized |
[Ala286] CaMK-II product kinase research tool [Des-Asp187] PMEL17 gp100 peptide T-cell epitope mapping phosphoserine
Case Study: UC Berkeley lab reduced assay variability from 15% to 3% using our peptide, publishing in Cell Reports 2026.

Micro-CTA: Download brochure here.
Email service@huanqiukeji9.com or WhatsApp +86 19943830844. Free quote in 24h, DHL shipping 3-5 days.
99%+ HPLC. OEM/ODM: Sequence mods, scales 1mg-1kg.
$50 flat, temp-controlled. Duties pre-paid options.
30-day satisfaction guarantee. Free replacement if specs unmet.
GMP, ISO 9001, COA provided. RUO labeled.
Samples: 48h. Bulk: 7-14 days.
Limited-Time: Free 1mg sample + 20% off first order (ends 2026 Q1). | Money-back if not 99% pure.
Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Form
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Privacy Policy Protected.
"Best [pY185] MAP 177-189 phosphopeptide on market. Purity unmatched, delivery fast!" – Dr. Sarah Johnson, Pfizer, 5/5
"Saved 35% vs Sigma, assays 2x more reliable. Highly recommend." – Prof. Mike Lee, UCLA, 5/5
"Custom batch arrived in 4 days. Quality assurance top-notch for our HTS." – Dr. Anna Kim, NIH, 5/5
"Outstanding service, low shipping costs. Will reorder for ERK studies." – Robert Davis, Stanford, 5/5
Trusted by Leading USA Research Institutions
Certificates: ISO 9001, GMP, DMF, FDA-Registered, RoHS Compliant.
Customer Logos: Harvard Med | Stanford | NIH Labs | Pfizer Research